Endometrial Cancer Trial, Recruiting (NCT04661072)

Endometrial Cancer Trial, Recruiting NCT04661072 Sponsor: Yale University Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04661072 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are female
People who are 13 years of age or older
People who have received care at Yale New Haven Hospital, Bridgeport Hospital, Greenwich Hospital, or Lawrence + Memorial Hospital
People who have been diagnosed with any form of CUA (calciphylaxis, a condition affecting blood vessels and skin)

Who may not be able to join:

People who do not wish to take part in the study when contacted
People who do not speak English, with the exception of Spanish speakers, who may still be eligible
People who are unable to take part in the consent or agreement process due to a mental disability

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alla Vash-Margita, MD, Yale University

Phone: 203-785-4010

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04661072

Sponsor: Yale University

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: 203-785-4010

More information: https://clinicaltrials.gov/study/NCT04661072

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are female
People who are 13 years of age or older
People who have received care at Yale New Haven Hospital, Bridgeport Hospital, Greenwich Hospital, or Lawrence + Memorial Hospital
People who have been diagnosed with any form of CUA (calciphylaxis, a condition affecting blood vessels and skin)

Who may not be able to join:

People who do not wish to take part in the study when contacted
People who do not speak English, with the exception of Spanish speakers, who may still be eligible
People who are unable to take part in the consent or agreement process due to a mental disability

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Yale University

Registry

ClinicalTrials.gov

Start date

14 July 2021

Est. completion

1 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Prevalence of breast cancer in women with CUA's compared to women without CUA's; Prevalence of ovarian cancer in women with CUA's compared to women without CUA's; Prevalence of uterine cancer in women with CUA's compared to women without CUA's; Prevalence of cervical cancer in women with CUA's compared to women without CUA's; Prevalence of vaginal cancer in women with CUA's compared to women without CUA's; Prevalence of renal cancer in women with CUA's compared to women without CUA's

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov